drugset / Trial / NCT04052412

Biodistribution and Kinetics of 18F-AraG in Non-Small Cell Lung Cancer

NCT04052412 ↗

Non-randomizedParallel-groupSingle-blindBasic science

Summary

This study is to assess the biodistribution and kinetics of a novel T-cell imaging agent in non-small cell lung cancer patients undergoing immunotherapy with and without adjuvant radiation therapy. This study is assessing the change in kinetics that occurs in this patient population to better understand the distribution of this compound in patient disease circumstances.

Timeline

Start
2019-07-16
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject F-ARAG Diagnostic / imaging agent — Other